Risk of the Development of Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Rheumatoid Arthritis
Introduction: Individuals diagnosed with rheumatoid arthritis (RA) face a heightened risk of developing metabolic dysfunction-associated fatty liver disease (MAFLD). The primary objective of this study was to examine the progression of hepatic fibrosis through non-invasive tests in patients with MAF...
Main Authors: | Murat Aydın, Berrin Aksakal, Sema Basat |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-11-01
|
Series: | İstanbul Medical Journal |
Subjects: | |
Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/risk-of-the-development-of-fibrosis-in-metabolic-d/63653
|
Similar Items
-
A Noninvasive Scoring System for Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
by: Moniyka Sachar, et al.
Published: (2022-01-01) -
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
by: Mayada Metwally, et al.
Published: (2021-08-01) -
Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients
by: Wei Zhang, et al.
Published: (2023-12-01) -
Mitochondrial Dysfunction in Rheumatoid Arthritis
by: Chen Ma, et al.
Published: (2022-09-01) -
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
by: Stefano Ciardullo, et al.
Published: (2021-07-01)